Tribio InVivoMAb Anti-Human TREM1 & CD46 Bispecific Antibody (TBS10464)
$369.00 – $1,479.00
| SKU | Stock | SIZE (mg) | Price | Quantity | ||
|---|---|---|---|---|---|---|
| TBS10464-100 | Yes | 100 UG | $369.00 | |||
| TBS10464-1 | Yes | 1 MG | $1,479.00 |
- Description
- Terms
- Additional information
- Reviews (0)
Description
Description: Tribio TREM1 & CD46 InVivoMAb Bispecific Antibody is a recombinant antibody designed to simultaneously target TREM1 and CD46 on human cells, both of which are involved in innate immune regulation and complement system control. It is used in immunology and inflammation research to study myeloid cell activation, complement regulatory pathways, and immune modulation in infectious and inflammatory disease models.
Applications: ELISA, Neutralization
Species reactivity: Human
Target: TREM1, Triggering receptor expressed on monocytes 1, Triggering receptor expressed on myeloid cells 1, TREM-1, CD354, Trophoblast leukocyte common antigen, CD46, TLX, MCP, Membrane cofactor protein, MIC10
Isotype: BiTE-bispecific antibody
Accession/UniProt: Q9NP99 & P15529
Concentration: 3 mg/ml
Purity: >95%
Formulation: Liquid
Storage buffer: 0.01M PBS, pH 7.4
Purification: Purified by Nickel column.
Clonality: Monoclonal
Storage: Avoid repeated freeze-thaw cycles. -20°C for 12 months; -80°C for long-term storage.
Research use only.
Additional information
| SIZE (mg) | 1 MG, 100 UG |
|---|
Be the first to review “Tribio InVivoMAb Anti-Human TREM1 & CD46 Bispecific Antibody (TBS10464)”
You must be logged in to post a review.
Reviews
There are no reviews yet.